GeneDx Hldgs (NASDAQ:WGS) reported quarterly earnings of $0.31 per share which beat the analyst consensus estimate of $(0.01) by 3200 percent. This is a 14.81 percent increase over earnings of $0.27 per share from the same period last year. The company reported quarterly sales of $102.300 million which missed the analyst consensus estimate of $112.956 million by 9.43 percent. This is a 17.43 percent increase over sales of $87.115 million the same period last year.